[Neutrophils as tumor microenviroment member]
- PMID: 30444330
[Neutrophils as tumor microenviroment member]
Abstract
Conception of the neutrophils role in the immune system has been changed significantly in the recent time. Many studies prove important and diversified role of this cells in the cancer biology in the last few years. It was shown that their presence in tumor microenvironment has mixed role on cancer growth. This review summaries evidence of neutrophils heterogeneity, plasticity and ability to differentiate into other myeloid types of cells despite formed proinflammatory potential. Prognostic value of tumor-associated neutrophils and high neutrophil level in peripheral blood in patients with different type of malignancies (i.e. renal cell cancer, melanoma, colorectal cancer, hepatocellular cancer, cholangiocarcinoma, glioblastoma, gastrointestinal stromal tumors, gastric cancer, lung cancer, ovarian cancer, head and neck cancer) is discussed. More sophisticated study of existence and functional activity of pro- and antitumor abilities of neutrophils is needed for finding new diagnostic and therapeutic approaches in oncology.
Similar articles
-
Cancer-related circulating and tumor-associated neutrophils - subtypes, sources and function.FEBS J. 2018 Dec;285(23):4316-4342. doi: 10.1111/febs.14524. Epub 2018 Jun 14. FEBS J. 2018. PMID: 29851227 Review.
-
Neutrophils as active regulators of the immune system in the tumor microenvironment.J Leukoc Biol. 2017 Aug;102(2):343-349. doi: 10.1189/jlb.5MR1216-508R. Epub 2017 Mar 6. J Leukoc Biol. 2017. PMID: 28264904 Review.
-
Roles of neutrophils in cancer growth and progression.J Leukoc Biol. 2018 Mar;103(3):457-464. doi: 10.1002/JLB.3MR0717-292R. Epub 2017 Dec 15. J Leukoc Biol. 2018. PMID: 29345348 Review.
-
Tumor-associated neutrophils: friend or foe?Carcinogenesis. 2012 May;33(5):949-55. doi: 10.1093/carcin/bgs123. Epub 2012 Mar 16. Carcinogenesis. 2012. PMID: 22425643 Review.
-
Neutrophil Heterogeneity in Cancer: From Biology to Therapies.Front Immunol. 2019 Sep 20;10:2155. doi: 10.3389/fimmu.2019.02155. eCollection 2019. Front Immunol. 2019. PMID: 31616408 Free PMC article. Review.
Cited by
-
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.Curr Oncol. 2023 Jan 11;30(1):1032-1045. doi: 10.3390/curroncol30010079. Curr Oncol. 2023. PMID: 36661728 Free PMC article.
-
Circulating Neutrophils Predict Poor Survival for HCC and Promote HCC Progression Through p53 and STAT3 Signaling Pathway.J Cancer. 2020 Apr 6;11(13):3736-3744. doi: 10.7150/jca.42953. eCollection 2020. J Cancer. 2020. PMID: 32328178 Free PMC article.
-
C-Reactive Protein Pretreatment-Level Evaluation for Ewing's Sarcoma Prognosis Assessment-A 15-Year Retrospective Single-Centre Study.Cancers (Basel). 2022 Nov 29;14(23):5898. doi: 10.3390/cancers14235898. Cancers (Basel). 2022. PMID: 36497377 Free PMC article.
-
Influence of Combined Therapy on Generation of Neutrophil Extracellular Traps in Patients with Cervical Cancer.Open Access Maced J Med Sci. 2018 Nov 20;6(11):2097-2100. doi: 10.3889/oamjms.2018.483. eCollection 2018 Nov 25. Open Access Maced J Med Sci. 2018. PMID: 30559867 Free PMC article.